Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M111,531Revenue $M20,437Net Margin (%)8.9Altman Z-Score4.0
Enterprise Value $M114,859EPS $1.1Operating Margin %18.3Piotroski F-Score7
P/E(ttm)63.1Beneish M-Score-2.9Pre-tax Margin (%)12.1Higher ROA y-yN
Price/Book81.510-y EBITDA Growth Rate %--Quick Ratio1.3Cash flow > EarningsY
Price/Sales5.55-y EBITDA Growth Rate %--Current Ratio1.4Lower Leverage y-yY
Price/Free Cash Flow28.8y-y EBITDA Growth Rate %-43.2ROA % (ttm)6.5Higher Current Ratio y-yN
Dividend Yield %2.8PEG--ROE % (ttm)51.4Less Shares Outstanding y-yY
Payout Ratio %155Shares Outstanding M1,593ROIC % (ttm)28.6Gross Margin Increase y-yY

Gurus Latest Trades with ABBV

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ABBVKen Fisher 2015-06-30 Reduce$57.01 - $70.46
($65.18)
$ 70.017%Reduce 0.40%1,006,679
ABBVNWQ Managers 2015-03-31 Add1.27%$55.48 - $67.63
($60.41)
$ 70.0116%Add 1815.34%1,839,012
ABBVJoel Greenblatt 2015-03-31 Add0.25%$55.48 - $67.63
($60.41)
$ 70.0116%Add 6238.89%555,223
ABBVFirst Eagle Investment 2015-03-31 Sold Out -0.16%$55.48 - $67.63
($60.41)
$ 70.0116%Sold Out0
ABBVDavid Dreman 2015-03-31 Buy 0.05%$55.48 - $67.63
($60.41)
$ 70.0116%New holding9,655
ABBVDodge & Cox 2015-03-31 Reduce$55.48 - $67.63
($60.41)
$ 70.0116%Reduce 7.88%35,055
ABBVMario Gabelli 2015-03-31 Add$55.48 - $67.63
($60.41)
$ 70.0116%Add 36.62%47,212
ABBVKen Fisher 2015-03-31 Add$55.48 - $67.63
($60.41)
$ 70.0116%Add 0.96%1,010,756
ABBVJohn Paulson 2014-12-31 Sold Out -3.1%$52.9 - $69.71
($63.24)
$ 70.0111%Sold Out0
ABBVSteve Mandel 2014-12-31 Sold Out -1.2%$52.9 - $69.71
($63.24)
$ 70.0111%Sold Out0
ABBVGeorge Soros 2014-12-31 Sold Out -0.66%$52.9 - $69.71
($63.24)
$ 70.0111%Sold Out0
ABBVFirst Eagle Investment 2014-12-31 Buy 0.16%$52.9 - $69.71
($63.09)
$ 70.0111%New holding1,016,097
ABBVMario Gabelli 2014-12-31 Add0.01%$52.9 - $69.71
($63.09)
$ 70.0111%Add 232.85%34,557
ABBVJohn Paulson 2014-09-30 Buy 3.1%$52.05 - $59.62
($55.51)
$ 70.0126%New holding13,000,000
ABBVSteve Mandel 2014-09-30 Buy 1.2%$52.05 - $59.62
($55.51)
$ 70.0126%New holding5,247,201
ABBVGeorge Soros 2014-09-30 Add0.6%$52.05 - $59.62
($55.51)
$ 70.0126%Add 924.76%1,537,146
ABBVJoel Greenblatt 2014-09-30 Reduce-0.06%$52.05 - $59.62
($55.51)
$ 70.0126%Reduce 89.36%9,460
ABBVJoel Greenblatt 2014-06-30 Reduce-0.11%$46.46 - $56.79
($52.4)
$ 70.0134%Reduce 61.19%88,923
ABBVGeorge Soros 2014-06-30 Reduce-0.1%$46.46 - $56.79
($52.4)
$ 70.0134%Reduce 57.14%150,000
ABBVKen Fisher 2014-06-30 Add0.06%$46.46 - $56.79
($52.4)
$ 70.0134%Add 76.13%1,104,609
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ABBV is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


ABBV: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
GONZALEZ RICHARD AChairman of the Board and CEO 2015-07-29Sell40,021$71.24-1.73view
GONZALEZ RICHARD AChairman of the Board and CEO 2015-07-29Sell24,979$71.09-1.52view
HURWICH THOMAS A.VP, Controller 2015-05-19Sell6,200$666.08view
GONZALEZ RICHARD AChairman of the Board and CEO 2015-04-28Sell8,281$64.927.84view
GONZALEZ RICHARD AChairman of the Board and CEO 2015-04-28Sell64,232$64.847.97view
GONZALEZ RICHARD AChairman of the Board and CEO 2015-04-28Sell102,964$64.678.26view
RICHMOND TIMOTHY J.SVP, Human Resources 2015-03-02Sell14,388$60.3316.05view
Schumacher Laura JEVP, Bus.Dev.,Ext.Aff.&GC 2015-03-02Sell25,000$60.316.1view
HURWICH THOMAS A.VP, Controller 2015-02-27Sell1,185$60.5715.59view
SALEKI-GERHARDT AZITASVP, Operations 2015-02-27Sell2,112$60.4715.78view

Quarterly/Annual Reports about ABBV:

News about ABBV:

Articles On GuruFocus.com
dividend growth Jul 27 2015 
dividend growth Jul 27 2015 
dividend growth Jul 27 2015 
dividend growth Jul 27 2015 
dividend growth Jul 27 2015 
It’s Not Too Late To Buy Gilead Sciences Jul 17 2015 
Enanta is growing thanks to collaborations. Jun 29 2015 
Larry Robbins' New Buys During Q1 2015 May 29 2015 
Abbvie Inc. Dividend Stock Analysis May 26 2015 
Scott Black's Most Heavily Weighted Trades In Q1 2015 May 21 2015 

More From Other Websites
Highway Bill to Spend $500 Million for Veterans’ Hepatitis Drugs Jul 31 2015
NBIX: Three More Data Readouts Coming in the Second Half of 2015 - Analyst Blog Jul 30 2015
NBIX: Three More Data Readouts Coming in the Second Half of 2015… Jul 30 2015
The Zacks Analyst Blog Highlights: Biogen, AbbVie, Regeneron, Amgen and XOMA - Press Releases Jul 30 2015
HUMIRA® (Adalimumab) Approved by European Commission for Moderate to Severe Hidradenitis... Jul 30 2015
Biotech Stock Roundup: Biogen Down on Tecfidera Issues, Regeneron's Praluent Gets FDA Nod - Analyst... Jul 29 2015
AbbVie (ABBV) Stock Price Target Raised at Deutsche Bank Jul 29 2015
Eli Lilly & Co. Earnings Analysis: By the Numbers Jul 29 2015
Bristol-Myers Squibb Co. Earnings Analysis: By the Numbers Jul 29 2015
Gilead Lifts Sales View As Hep C Drugs Top Jul 28 2015
Gilead higher after earnings beat Jul 28 2015
Express Scripts Raises Guidance as Earnings Top Views Jul 28 2015
Leon Cooperman: Allergan trying to move up Jul 28 2015
Gilead Sales Soar on Hepatitis Drugs Jul 28 2015
Gilead Sciences: How Will the Market React to Slowing U.S. Hep-C Sales? Jul 28 2015
New drug approval is a win for the Bay State's horse in the hepatitis C race Jul 28 2015
The Zacks Analyst Blog Highlights: Gilead Sciences, AbbVie, Merck, Achillion Pharmaceuticals and... Jul 28 2015
Merck Targets Toughest Cases for Foothold in Hepatitis C Market Jul 28 2015
Gilead Sciences: Sure, It's Hep-C But It's Not Just Hep-C Jul 27 2015

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK